IL250804A0 - Imaging means for the huntingtin protein - Google Patents

Imaging means for the huntingtin protein

Info

Publication number
IL250804A0
IL250804A0 IL250804A IL25080417A IL250804A0 IL 250804 A0 IL250804 A0 IL 250804A0 IL 250804 A IL250804 A IL 250804A IL 25080417 A IL25080417 A IL 25080417A IL 250804 A0 IL250804 A0 IL 250804A0
Authority
IL
Israel
Prior art keywords
probes
huntingtin protein
imaging
imaging huntingtin
protein
Prior art date
Application number
IL250804A
Other languages
English (en)
Hebrew (he)
Inventor
Dominguez Celia
Wityak John
Bard Jonathan
John Brown Christopher
Edward Prime Michael
David Johnson Peter
CLARK-FREW Daniel
Rene Gabriel Galan Sebastien
Richard Giles Paul
Martin Krulle Thomas
Alexander Weddell Derek
Simon Walter Daryl
James WIGGINTON Ian
George Taylor Malcolm
Morao Inaki
Original Assignee
Chdi Foundation Inc
Dominguez Celia
Wityak John
Bard Jonathan
John Brown Christopher
Edward Prime Michael
David Johnson Peter
CLARK-FREW Daniel
Rene Gabriel Galan Sebastien
Richard Giles Paul
Martin Krulle Thomas
Alexander Weddell Derek
Simon Walter Daryl
James WIGGINTON Ian
George Taylor Malcolm
Morao Inaki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chdi Foundation Inc, Dominguez Celia, Wityak John, Bard Jonathan, John Brown Christopher, Edward Prime Michael, David Johnson Peter, CLARK-FREW Daniel, Rene Gabriel Galan Sebastien, Richard Giles Paul, Martin Krulle Thomas, Alexander Weddell Derek, Simon Walter Daryl, James WIGGINTON Ian, George Taylor Malcolm, Morao Inaki filed Critical Chdi Foundation Inc
Publication of IL250804A0 publication Critical patent/IL250804A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/0412Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K51/0419Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6823Release of bound markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D253/00Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
IL250804A 2014-08-29 2017-02-27 Imaging means for the huntingtin protein IL250804A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462043617P 2014-08-29 2014-08-29
PCT/US2015/047427 WO2016033460A1 (en) 2014-08-29 2015-08-28 Probes for imaging huntingtin protein

Publications (1)

Publication Number Publication Date
IL250804A0 true IL250804A0 (en) 2017-04-30

Family

ID=55400659

Family Applications (1)

Application Number Title Priority Date Filing Date
IL250804A IL250804A0 (en) 2014-08-29 2017-02-27 Imaging means for the huntingtin protein

Country Status (14)

Country Link
US (1) US10907197B2 (cg-RX-API-DMAC7.html)
EP (1) EP3190888B1 (cg-RX-API-DMAC7.html)
JP (1) JP2017528520A (cg-RX-API-DMAC7.html)
KR (1) KR20170047341A (cg-RX-API-DMAC7.html)
CN (1) CN107105655A (cg-RX-API-DMAC7.html)
AU (2) AU2015308709B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017004134A2 (cg-RX-API-DMAC7.html)
CA (1) CA2959505A1 (cg-RX-API-DMAC7.html)
EA (1) EA201790408A1 (cg-RX-API-DMAC7.html)
ES (1) ES2818107T3 (cg-RX-API-DMAC7.html)
IL (1) IL250804A0 (cg-RX-API-DMAC7.html)
MX (1) MX2017002705A (cg-RX-API-DMAC7.html)
SG (1) SG11201701580XA (cg-RX-API-DMAC7.html)
WO (1) WO2016033460A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107108534B (zh) 2014-08-29 2023-05-09 Chdi基金会股份有限公司 用于成像亨廷顿蛋白的探针
SI3197277T1 (sl) 2014-08-29 2022-04-29 Chdi Foundation, Inc. Sonde za slikanje proteina huntingtina
CA2959531C (en) 2014-08-29 2023-01-10 Chdi Foundation, Inc. Probes for imaging huntingtin protein
PL3340796T3 (pl) 2015-08-28 2022-02-21 Chdi Foundation, Inc. Sondy do obrazowania białka huntingtyny
CN106632002A (zh) * 2016-09-28 2017-05-10 贵州大学 一种依托考昔及其对照品5‑氯‑3‑(4‑(甲基磺酰基)苯基)‑2,3‑联吡啶的制备工艺
GB201617339D0 (en) 2016-10-12 2016-11-23 Lytix Biopharma As Therapeutic compounds
CN108178764A (zh) * 2018-01-09 2018-06-19 天津科技大学 呋喃并[2,3-b]吡啶类化合物及无金属催化的合成方法
US11389438B2 (en) 2019-02-25 2022-07-19 Chdi Foundation, Inc. Compounds for targeting mutant huntingtin protein and uses thereof
EP4192819A1 (en) * 2020-08-06 2023-06-14 CHDI Foundation, Inc. Heterobiaryl compounds and imaging agents for imaging huntingtin protein
MX2023011888A (es) * 2021-04-08 2023-12-06 Chdi Foundation Inc Compuestos de isoindolinona y agentes de formación de imágenes para la obtencion de imágenes de la proteína huntingtina.

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1367836A (en) * 1918-04-29 1921-02-08 Int Precipitation Co Process for obtaining chlorids of potassium or other metals
US3985755A (en) * 1972-06-02 1976-10-12 E. R. Squibb & Sons, Inc. Pyridine containing isothiocyanobenzoxazoles
FR2524468B1 (fr) * 1982-04-06 1985-10-18 Sandoz Sa Nouveaux derives condenses du thiophene, leur preparation et leur utilisation comme azurants optiques
JPS60146877A (ja) * 1984-01-11 1985-08-02 Chisso Corp 2―置換―6―(5―置換―2―ピリミジニル)ナフタリン
JPH11171886A (ja) * 1997-12-08 1999-06-29 Mitsui Chem Inc アミジンまたはグアニジンを側鎖にもつピロリルベンズイミダゾール誘導体
DE60213856T2 (de) * 2001-12-20 2007-09-13 Wyeth Indolylalkylamin-derivate als 5-hydroxytryptamin-6 liganden
CN1784392A (zh) * 2003-03-14 2006-06-07 匹兹堡大学 苯并噻唑衍生物化合物、组合物及用途
CA2438032C (en) 2003-03-14 2013-05-07 University Of Pittsburgh Benzothiazole derivative compounds, compositions and uses
WO2005040337A2 (en) 2003-05-20 2005-05-06 The Regents Of The University Of California METHODS FOR BINDING AGENTS TO β-AMYLOID PLAQUES
WO2005016384A1 (ja) * 2003-08-13 2005-02-24 Bf Research Institute, Inc. アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤
EP2054060B1 (en) 2006-08-24 2014-04-02 Australian Nuclear Science & Technology Organisation Fluorinated ligands for targeting peripheral benzodiazepine receptors
US7858803B2 (en) 2007-04-27 2010-12-28 The General Hospital Corporation Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
KR101469275B1 (ko) * 2007-06-01 2014-12-08 재단법인서울대학교산학협력재단 베타아밀로이드 침착의 영상화를 위한 헤테로사이클릭 인덴계열의 유도체 및 그의 방사성 동위원소 표지화합물
US20090123373A1 (en) 2007-11-05 2009-05-14 Yanming Wang Amyloid-imaging agents
US8153813B2 (en) 2007-12-20 2012-04-10 Abbott Laboratories Benzothiazole and benzooxazole derivatives and methods of use
WO2009146388A1 (en) * 2008-05-28 2009-12-03 The Trustees Of Columbia University In The City Of New York Voxel-based methods for assessing subjects using positron emission tomography
JP2011524864A (ja) * 2008-05-30 2011-09-08 メルク・シャープ・エンド・ドーム・コーポレイション 新規な置換されたアザベンゾオキサゾール
WO2010051196A1 (en) * 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel substituted azabenzoxazoles
US8691187B2 (en) 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
GB0905664D0 (en) 2009-04-02 2009-05-13 Summit Corp Plc Compounds for treatment of duchenne muscular dystrophy
CN102388055B (zh) * 2009-04-02 2015-07-29 卡洛斯三世国家癌症研究中心基金会 咪唑并[2,1-b][1,3,4]噻二唑衍生物
EP2501696B1 (en) 2009-10-15 2016-12-28 Guerbet Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
JP2011168515A (ja) * 2010-02-17 2011-09-01 Kowa Co エリスロポエチン産生促進作用を有する2−アリールベンゾオキサゾール化合物
CN107108534B (zh) 2014-08-29 2023-05-09 Chdi基金会股份有限公司 用于成像亨廷顿蛋白的探针
SI3197277T1 (sl) 2014-08-29 2022-04-29 Chdi Foundation, Inc. Sonde za slikanje proteina huntingtina
CA2959531C (en) 2014-08-29 2023-01-10 Chdi Foundation, Inc. Probes for imaging huntingtin protein
PL3340796T3 (pl) 2015-08-28 2022-02-21 Chdi Foundation, Inc. Sondy do obrazowania białka huntingtyny

Also Published As

Publication number Publication date
AU2020202226A1 (en) 2020-04-16
SG11201701580XA (en) 2017-03-30
AU2015308709A1 (en) 2017-03-23
JP2017528520A (ja) 2017-09-28
CN107105655A (zh) 2017-08-29
MX2017002705A (es) 2017-12-20
US20170292150A1 (en) 2017-10-12
KR20170047341A (ko) 2017-05-04
US10907197B2 (en) 2021-02-02
AU2015308709B2 (en) 2020-01-02
CA2959505A1 (en) 2016-03-03
EP3190888A4 (en) 2018-05-09
BR112017004134A2 (pt) 2017-12-12
EA201790408A1 (ru) 2017-09-29
ES2818107T3 (es) 2021-04-09
WO2016033460A1 (en) 2016-03-03
EP3190888B1 (en) 2020-06-10
EP3190888A1 (en) 2017-07-19

Similar Documents

Publication Publication Date Title
IL250803A0 (en) Imaging means for the huntingtin protein
GB201417164D0 (en) Measurement Probe
IL250805B (en) Imaging means for the huntingtin protein
GB201413245D0 (en) ImAGE Analysis
IL250804A0 (en) Imaging means for the huntingtin protein
IL250802B (en) Imaging means for the huntingtin protein
GB201500641D0 (en) Ultrasound probe
EP3197341A4 (en) Probe for iridocorneal angle imaging
IL257537B (en) Antigen protein imaging markers
IL259034B (en) Test device cover
SG11201606516RA (en) Probe unit
SG11201702178TA (en) Probe unit
GB2533151B (en) Improved probe
HK40110855A (zh) 用於成像亨廷顿蛋白的探针
GB2550120B (en) Probe
GB201517390D0 (en) Protein variant analysis
HK1241224A1 (en) Probes for imaging huntingtin protein
HK1240583A1 (en) Probes for imaging huntingtin protein
GB201407787D0 (en) Imaging techniques